Human medicines European public assessment report (EPAR): Thalidomide Lipomed, thalidomide, Date of authorisation: 19/09/2022, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Thalidomide Lipomed, thalidomide, Date of authorisation: 19/09/2022, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Axitinib Accord, axitinib, Date of authorisation: 19/09/2024, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Axitinib Accord, axitinib, Date of authorisation: 19/09/2024, Revision: 3, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness